159 related articles for article (PubMed ID: 1282428)
1. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
2. Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis.
Robertson LE; Huh YO; Butler JJ; Pugh WC; Hirsch-Ginsberg C; Stass S; Kantarjian H; Keating MJ
Blood; 1992 Jul; 80(1):29-36. PubMed ID: 1377051
[TBL] [Abstract][Full Text] [Related]
3. Association of bone marrow growth pattern, coexpression of CD14, and B-cell CD5 antigen density in 45 B-chronic lymphocytic leukemia (B-CLL) patients.
Paglieroni T; Caggiano V; MacKenzie MR
Ann N Y Acad Sci; 1992 May; 651():484-5. PubMed ID: 1376066
[No Abstract] [Full Text] [Related]
4. Rearrangements of immunoglobulin light and heavy chain genes and correlation with phenotypic markers in B-cell chronic lymphocytic leukemia.
Lenormand B; Ghanem N; Tilly H; Boussemart C; Monconduit M; Piguet H; Lefranc G; Lefranc MP
Leukemia; 1991 Nov; 5(11):928-36. PubMed ID: 1961033
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.
Deane M; Norton JD
Eur J Immunol; 1990 Oct; 20(10):2209-17. PubMed ID: 1700749
[TBL] [Abstract][Full Text] [Related]
6. Extensive and selective mutation of a rearranged VH5 gene in human B cell chronic lymphocytic leukemia.
Cai J; Humphries C; Richardson A; Tucker PW
J Exp Med; 1992 Oct; 176(4):1073-81. PubMed ID: 1402653
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin V gene expression in CD5 B-cell malignancies.
Kipps TJ; Rassenti LZ; Duffy S; Johnson T; Kobayashi R; Carson DA
Ann N Y Acad Sci; 1992 May; 651():373-83. PubMed ID: 1376056
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymphocyte surface markers in acute myeloid leukemia.
Ball ED; Davis RB; Griffin JD; Mayer RJ; Davey FR; Arthur DC; Wurster-Hill D; Noll W; Elghetany MT; Allen SL
Blood; 1991 May; 77(10):2242-50. PubMed ID: 1709379
[TBL] [Abstract][Full Text] [Related]
10. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
[TBL] [Abstract][Full Text] [Related]
11. Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia.
Friedman DF; Moore JS; Erikson J; Manz J; Goldman J; Nowell PC; Silberstein LE
Blood; 1992 Nov; 80(9):2287-97. PubMed ID: 1421400
[TBL] [Abstract][Full Text] [Related]
12. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells.
Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE
J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243
[TBL] [Abstract][Full Text] [Related]
13. Normal B cell compartment in chronic lymphatic leukemia.
Pluta A; Górski A; Nowaczyk M; Modlińska M
Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
[TBL] [Abstract][Full Text] [Related]
14. Intraclonal diversity in the VH genes expressed by CD5- chronic lymphocytic leukemia-producing pathologic IgM rheumatoid factor.
Roudier J; Silverman GJ; Chen PP; Carson DA; Kipps TJ
J Immunol; 1990 Feb; 144(4):1526-30. PubMed ID: 1689356
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.
Batata A; Shen B
Cancer; 1992 Nov; 70(10):2436-43. PubMed ID: 1384948
[TBL] [Abstract][Full Text] [Related]
16. B cells of chronic lymphatic leukemia express V genes in unmutated form.
Küppers R; Gause A; Rajewsky K
Leuk Res; 1991; 15(6):487-96. PubMed ID: 1713635
[TBL] [Abstract][Full Text] [Related]
17. Analysis of VH251 gene mutation in chronic lymphocytic leukemia (CLL) and normal B-cell subsets.
Cai J; Humphries C; Lutz C; Tucker PW
Ann N Y Acad Sci; 1992 May; 651():384-92. PubMed ID: 1599132
[TBL] [Abstract][Full Text] [Related]
18. Changing antigen receptor gene rearrangements in a case of early pre-B cell leukemia: evidence for a tumor progenitor cell with stem cell features and implications for monitoring residual disease.
Tycko B; Ritz J; Sallan S; Sklar J
Blood; 1992 Jan; 79(2):481-8. PubMed ID: 1309670
[TBL] [Abstract][Full Text] [Related]
19. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.
Vuillier F; Scott-Algara D; Tortevoye P; Pialoux G; Dighiero G
Clin Exp Immunol; 1991 Sep; 85(3):476-80. PubMed ID: 1716542
[TBL] [Abstract][Full Text] [Related]
20. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse.
Neale GA; Menarguez J; Kitchingman GR; Fitzgerald TJ; Koehler M; Mirro J; Goorha RM
Blood; 1991 Aug; 78(3):739-47. PubMed ID: 1859886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
